Barclays’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
Barclays's REPL Position: Q3 2026 in Review
Barclays increased its Replimune Group (REPL) stake by 47% in Q3 2026, buying an estimated $1.34M and bringing the position to 332,977 shares worth $4.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.
Barclays first reported a position in REPL in Q3 2018 and has held it in 33 quarters since. 206 funds tracked by Wall St. Rank hold REPL as of Q3 2026.
- Barclays held 332,977 shares of Replimune Group worth $4.41M as of Q3 2026.
- Barclays bought 105,914 Replimune Group shares in Q3 2026, an estimated $1.34M.
- Replimune Group made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2112 holding.
- Barclays first reported a position in Replimune Group in Q3 2018 and has held it in 33 quarters since.
- 206 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.